Nomura Research Institute Ltd
TSE:4307
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 474
6 399
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
Nomura Research Institute Ltd
stock under the Base Case scenario is
4 481.55
JPY.
Compared to the current market price of 6 039 JPY,
Nomura Research Institute Ltd
is
Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Nomura Research Institute Ltd.
| US |
|
International Business Machines Corp
NYSE:IBM
|
|
| IE |
|
Accenture PLC
NYSE:ACN
|
|
| IN |
|
Tata Consultancy Services Ltd
NSE:TCS
|
|
| IN |
|
Infosys Ltd
NSE:INFY
|
|
| IN |
|
HCL Technologies Ltd
NSE:HCLTECH
|
|
| JP |
|
NEC Corp
TSE:6701
|
|
| JP |
|
Fujitsu Ltd
TSE:6702
|
|
| US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
|
| JP |
|
NTT Data Corp
TSE:9613
|
|
| JP |
N
|
NTT Data Group Corp
DUS:NT5
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Nomura Research Institute Ltd
Balance Sheet Decomposition
Nomura Research Institute Ltd
| Current Assets | 466.5B |
| Cash & Short-Term Investments | 197.3B |
| Receivables | 237.4B |
| Other Current Assets | 31.8B |
| Non-Current Assets | 528B |
| Long-Term Investments | 85.1B |
| PP&E | 68.1B |
| Intangibles | 284.1B |
| Other Non-Current Assets | 90.7B |
| Current Liabilities | 270.7B |
| Accounts Payable | 79.9B |
| Other Current Liabilities | 190.8B |
| Non-Current Liabilities | 246.5B |
| Long-Term Debt | 212.7B |
| Other Non-Current Liabilities | 33.8B |
Free Cash Flow Analysis
Nomura Research Institute Ltd
| JPY | |
| Free Cash Flow | JPY |
Earnings Waterfall
Nomura Research Institute Ltd
|
Revenue
|
785.1B
JPY
|
|
Cost of Revenue
|
-496.5B
JPY
|
|
Gross Profit
|
288.6B
JPY
|
|
Operating Expenses
|
-141.6B
JPY
|
|
Operating Income
|
147B
JPY
|
|
Other Expenses
|
-45.3B
JPY
|
|
Net Income
|
101.7B
JPY
|
Profitability Score
Profitability Due Diligence
Nomura Research Institute Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Nomura Research Institute Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Nomura Research Institute Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Nomura Research Institute Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Nomura Research Institute Ltd
According to Wall Street analysts, the average 1-year price target for
Nomura Research Institute Ltd
is 6 309.09 JPY
with a low forecast of 5 050 JPY and a high forecast of 7 140 JPY.
Dividends
Current shareholder yield for
Nomura Research Institute Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Nomura Research Institute Ltd
stock under the Base Case scenario is
4 481.55
JPY.
Compared to the current market price of 6 039 JPY,
Nomura Research Institute Ltd
is
Overvalued by 26%.